{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:54:41Z","timestamp":1790358881942,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T00:00:00Z","timestamp":1603152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#454088\/2014-0"],"award-info":[{"award-number":["#454088\/2014-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#400271\/2014-1"],"award-info":[{"award-number":["#400271\/2014-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#465.249\/2014-0"],"award-info":[{"award-number":["#465.249\/2014-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010688","name":"Instituto Nacional de Ci\u00eancia e Tecnologia da Criosfera","doi-asserted-by":"publisher","award":["#310082\/2016-1"],"award-info":[{"award-number":["#310082\/2016-1"]}],"id":[{"id":"10.13039\/501100010688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["(#CEX-APQ-00241-15"],"award-info":[{"award-number":["(#CEX-APQ-00241-15"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11064-020-03148-2","type":"journal-article","created":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T06:03:49Z","timestamp":1603173829000},"page":"3003-3020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases"],"prefix":"10.1007","volume":"45","author":[{"given":"Cindy Juliet Cristancho","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Miranda","family":"Damasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Pruccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nath\u00e1lia Fonseca","family":"Nadur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Luiza","family":"de Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella Alvim","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent Emmanuel","family":"Dardenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur Eugen","family":"K\u00fcmmerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tarozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7799-992X","authenticated-orcid":false,"suffix":"Jr.","given":"Claudio","family":"Viegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,20]]},"reference":[{"key":"3148_CR1","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1517\/14656566.8.7.1011","volume":"8","author":"B Seltzer","year":"2007","unstructured":"Seltzer B (2007) Donepezil: an update. Expert Opin Pharmacother 8:1011\u20131023. https:\/\/doi.org\/10.1517\/14656566.8.7.1011","journal-title":"Expert Opin Pharmacother"},{"key":"3148_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/J.PHAREP.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, Singh A (2015) A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol Rep 67:195\u2013203. https:\/\/doi.org\/10.1016\/J.PHAREP.2014.09.004","journal-title":"Pharmacol Rep"},{"key":"3148_CR3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S1474-4422(17)30004-2","volume":"16","author":"V Voon","year":"2017","unstructured":"Voon V, Napier TC, Frank MJ et al (2017) Impulse control disorders and levodopa-induced dyskinesias in Parkinson\u2019s disease: an update. Lancet Neurol 16:238\u2013250. https:\/\/doi.org\/10.1016\/S1474-4422(17)30004-2","journal-title":"Lancet Neurol"},{"key":"3148_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000486546","volume":"45","author":"R Knight","year":"2018","unstructured":"Knight R, Khondoker M, Magill N et al (2018) A systematic review and meta-analysis of the effectiveness of acetylcholinesterase inhibitors and memantine in treating the cognitive symptoms of dementia. Dement Geriatr Cogn Disord 45:131\u2013151. https:\/\/doi.org\/10.1159\/000486546","journal-title":"Dement Geriatr Cogn Disord"},{"key":"3148_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","volume":"15","author":"Y Hou","year":"2019","unstructured":"Hou Y, Dan X, Babbar M et al (2019) Ageing as a risk factor for neurodegenerative disease. Nat Rev Neurol 15:565\u2013581. https:\/\/doi.org\/10.1038\/s41582-019-0244-7","journal-title":"Nat Rev Neurol"},{"key":"3148_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4103\/1673-5374.266045","volume":"15","author":"A Popa-Wagner","year":"2020","unstructured":"Popa-Wagner A, Dumitrascu D, Capitanescu B et al (2020) Dietary habits, lifestyle factors and neurodegenerative diseases. Neural Regen Res 15:394. https:\/\/doi.org\/10.4103\/1673-5374.266045","journal-title":"Neural Regen Res"},{"key":"3148_CR7","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/j.1582-4934.2009.00897.x","volume":"14","author":"J-M L\u00fc","year":"2010","unstructured":"L\u00fc J-M, Lin PH, Yao Q, Chen C (2010) Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J Cell Mol Med 14:840\u2013860. https:\/\/doi.org\/10.1111\/j.1582-4934.2009.00897.x","journal-title":"J Cell Mol Med"},{"issue":"1","key":"3148_CR8","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1002\/mnfr.200700195","volume":"52","author":"AT Dinkova-Kostova","year":"2008","unstructured":"Dinkova-Kostova AT, Talalay P (2008) Direct and indirect antioxidant properties of inducers of cytoprotective proteins. Mol Nutr Food Res 52(1):S128\u2013S138. https:\/\/doi.org\/10.1002\/mnfr.200700195","journal-title":"Mol Nutr Food Res"},{"key":"3148_CR9","first-page":"255","volume-title":"Design of multi-target directed ligands as a modern approach for the development of innovative drug candidates for Alzheimer\u2019s disease","author":"CJC Ortiz","year":"2018","unstructured":"Ortiz CJC, de Freitas Silva M, Gontijo VS et al (2018) Design of multi-target directed ligands as a modern approach for the development of innovative drug candidates for Alzheimer\u2019s disease. Humana Press, New York, pp 255\u2013351"},{"key":"3148_CR10","doi-asserted-by":"publisher","first-page":"9967","DOI":"10.1021\/acs.jmedchem.6b01178","volume":"59","author":"M Benchekroun","year":"2016","unstructured":"Benchekroun M, Romero A, Egea J et al (2016) The antioxidant additive approach for alzheimer\u2019s disease therapy: new ferulic (Lipoic) acid plus melatonin modified tacrines as cholinesterases inhibitors, direct antioxidants, and nuclear factor (erythroid-derived 2)-like 2 activators. J Med Chem 59:9967\u20139973. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01178","journal-title":"J Med Chem"},{"key":"3148_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","volume":"7","author":"RR Ramsay","year":"2018","unstructured":"Ramsay RR, Popovic-Nikolic MR, Nikolic K et al (2018) A perspective on multi-target drug discovery and design for complex diseases. Clin Transl Med 7:3. https:\/\/doi.org\/10.1186\/s40169-017-0181-2","journal-title":"Clin Transl Med"},{"key":"3148_CR12","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ejmech.2017.02.043","volume":"130","author":"KST Dias","year":"2017","unstructured":"Dias KST, de Paula CT, dos Santos T et al (2017) Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 130:440\u2013457. https:\/\/doi.org\/10.1016\/j.ejmech.2017.02.043","journal-title":"Eur J Med Chem"},{"key":"3148_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/092986706775197881","volume":"13","author":"CAM Fraga","year":"2006","unstructured":"Fraga CAM, Barreiro EJ (2006) Medicinal chemistry of N-acylhydrazones: new lead-compounds of analgesic, antiinflammatory and antithrombotic drugs. Curr Med Chem 13:167\u2013198. https:\/\/doi.org\/10.2174\/092986706775197881","journal-title":"Curr Med Chem"},{"key":"3148_CR14","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.2174\/138955707782331722","volume":"7","author":"CD Duarte","year":"2007","unstructured":"Duarte CD, Barreiro EJ, Fraga CAM (2007) Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini Rev Med Chem 7:1108\u20131119. https:\/\/doi.org\/10.2174\/138955707782331722","journal-title":"Mini Rev Med Chem"},{"key":"3148_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395. https:\/\/doi.org\/10.1016\/0006-2952(61)90145-9","journal-title":"Biochem Pharmacol"},{"key":"3148_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ejmech.2017.03.062","volume":"132","author":"Q Li","year":"2017","unstructured":"Li Q, Yang H, Chen Y, Sun H (2017) Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer\u2019s disease. Eur J Med Chem 132:294\u2013309. https:\/\/doi.org\/10.1016\/j.ejmech.2017.03.062","journal-title":"Eur J Med Chem"},{"key":"3148_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2147\/CIA.S129145","volume":"12","author":"N Kandiah","year":"2017","unstructured":"Kandiah N, Pai M-C, Senanarong V et al (2017) Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson\u2019s disease dementia. Clin Interv Aging 12:697. https:\/\/doi.org\/10.2147\/CIA.S129145","journal-title":"Clin Interv Aging"},{"key":"3148_CR18","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1039\/c9cc01330j","volume":"55","author":"A Meden","year":"2019","unstructured":"Meden A, Knez D, Juki\u010d M et al (2019) Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer\u2019s disease. Chem Commun 55:3765\u20133768. https:\/\/doi.org\/10.1039\/c9cc01330j","journal-title":"Chem Commun"},{"key":"3148_CR19","doi-asserted-by":"publisher","first-page":"7683","DOI":"10.1021\/acs.jmedchem.6b00356","volume":"59","author":"SN Dighe","year":"2016","unstructured":"Dighe SN, Deora GS, De la Mora E et al (2016) Discovery and structure-activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening. J Med Chem 59:7683\u20137689. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00356","journal-title":"J Med Chem"},{"key":"3148_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","volume":"61","author":"U Ko\u0161ak","year":"2018","unstructured":"Ko\u0161ak U, Brus B, Knez D et al (2018) The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in vivo activity. J Med Chem 61:119\u2013139. https:\/\/doi.org\/10.1021\/acs.jmedchem.7b01086","journal-title":"J Med Chem"},{"key":"3148_CR21","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.3390\/molecules22122098","volume":"22","author":"T Rosenberry","year":"2017","unstructured":"Rosenberry T, Brazzolotto X, Macdonald I et al (2017) Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: a crystallographic, kinetic and calorimetric study. Molecules 22:2098. https:\/\/doi.org\/10.3390\/molecules22122098","journal-title":"Molecules"},{"key":"3148_CR22","doi-asserted-by":"publisher","first-page":"8167","DOI":"10.1021\/jm501195e","volume":"57","author":"B Brus","year":"2014","unstructured":"Brus B, Ko\u0161ak U, Turk S et al (2014) Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor. J Med Chem 57:8167\u20138179. https:\/\/doi.org\/10.1021\/jm501195e","journal-title":"J Med Chem"},{"key":"3148_CR23","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s12035-014-9053-6","volume":"53","author":"PK Kamat","year":"2016","unstructured":"Kamat PK, Kalani A, Rai S et al (2016) Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer\u2019s disease: understanding the therapeutics strategies. Mol Neurobiol 53:648\u2013661. https:\/\/doi.org\/10.1007\/s12035-014-9053-6","journal-title":"Mol Neurobiol"},{"key":"3148_CR24","doi-asserted-by":"publisher","first-page":"742","DOI":"10.4103\/1673-5374.230303","volume":"13","author":"M Chen","year":"2018","unstructured":"Chen M, Du Z-Y, Zheng X et al (2018) Use of curcumin in diagnosis, prevention, and treatment of Alzheimer\u2019s disease. Neural Regen Res 13:742\u2013752. https:\/\/doi.org\/10.4103\/1673-5374.230303","journal-title":"Neural Regen Res"},{"key":"3148_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2019.02.020","volume":"406","author":"S Abrahams","year":"2019","unstructured":"Abrahams S, Haylett WL, Johnson G et al (2019) Antioxidant effects of curcumin in models of neurodegeneration, aging, oxidative and nitrosative stress: a review. Neuroscience 406:1\u201321. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.02.020","journal-title":"Neuroscience"},{"key":"3148_CR26","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/J.LFS.2005.11.004","volume":"78","author":"Y-Z Cai","year":"2006","unstructured":"Cai Y-Z, Sun Mei, Xing Jie et al (2006) Structure\u2013radical scavenging activity relationships of phenolic compounds from traditional Chinese medicinal plants. Life Sci 78:2872\u20132888. https:\/\/doi.org\/10.1016\/J.LFS.2005.11.004","journal-title":"Life Sci"},{"key":"3148_CR27","doi-asserted-by":"publisher","first-page":"12149","DOI":"10.3390\/ijms150712149","volume":"15","author":"J-K Kim","year":"2014","unstructured":"Kim J-K, Jang H-D (2014) Nrf2-mediated HO-1 induction coupled with the erk signaling pathway contributes to indirect antioxidant capacity of caffeic acid phenethyl ester in HepG2 cells. Int J Mol Sci 15:12149\u201312165. https:\/\/doi.org\/10.3390\/ijms150712149","journal-title":"Int J Mol Sci"},{"key":"3148_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/MCO.0000000000000134","volume":"18","author":"F Gu","year":"2015","unstructured":"Gu F, Chauhan V, Chauhan A (2015) Glutathione redox imbalance in brain disorders. Curr Opin Clin Nutr Metab Care 18:89\u201395. https:\/\/doi.org\/10.1097\/MCO.0000000000000134","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"3148_CR29","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1111\/febs.14379","volume":"285","author":"AT Dinkova-Kostova","year":"2018","unstructured":"Dinkova-Kostova AT, Kostov RV, Kazantsev AG (2018) The role of Nrf2 signaling in counteracting neurodegenerative diseases. FEBS J 285:3576\u20133590. https:\/\/doi.org\/10.1111\/febs.14379","journal-title":"FEBS J"},{"key":"3148_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/J.BCP.2012.11.016","volume":"85","author":"HK Bryan","year":"2013","unstructured":"Bryan HK, Olayanju A, Goldring CE, Park BK (2013) The Nrf2 cell defence pathway: keap1-dependent and -independent mechanisms of regulation. Biochem Pharmacol 85:705\u2013717. https:\/\/doi.org\/10.1016\/J.BCP.2012.11.016","journal-title":"Biochem Pharmacol"},{"key":"3148_CR31","doi-asserted-by":"publisher","first-page":"865","DOI":"10.4103\/1673-5374.184447","volume":"11","author":"M Lalkovi\u010dov\u00e1","year":"2016","unstructured":"Lalkovi\u010dov\u00e1 M, Danielisov\u00e1 V (2016) Neuroprotection and antioxidants. Neural Regen Res 11:865\u2013874. https:\/\/doi.org\/10.4103\/1673-5374.184447","journal-title":"Neural Regen Res"},{"key":"3148_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0166-2236(00)01749-5","volume":"24","author":"W Klein","year":"2001","unstructured":"Klein W, Krafft G, Finch C (2001) Targeting small A\u03b2 oligomers: the solution to an Alzheimer\u2019s disease conundrum? Trends Neurosci 24:219\u2013224. https:\/\/doi.org\/10.1016\/S0166-2236(00)01749-5","journal-title":"Trends Neurosci"},{"key":"3148_CR33","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF03033565","volume":"11","author":"N Simola","year":"2007","unstructured":"Simola N, Morelli M, Carta AR (2007) The 6-hydroxydopamine model of parkinson\u2019s disease. Neurotox Res 11:151\u2013167. https:\/\/doi.org\/10.1007\/BF03033565","journal-title":"Neurotox Res"},{"key":"3148_CR34","doi-asserted-by":"publisher","first-page":"878","DOI":"10.3390\/molecules15020878","volume":"15","author":"I T\u00fanez","year":"2010","unstructured":"T\u00fanez I, Tasset I, La Cruz VP, De Santamar\u00eda A (2010) 3-Nitropropionic acid as a tool to study the mechanisms involved in huntington\u2019s disease: past, present and future. Molecules 15:878\u2013916. https:\/\/doi.org\/10.3390\/molecules15020878","journal-title":"Molecules"},{"key":"3148_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46:3\u201326. https:\/\/doi.org\/10.1016\/S0169-409X(00)00129-0","journal-title":"Adv Drug Deliv Rev"},{"key":"3148_CR36","doi-asserted-by":"publisher","first-page":"10282","DOI":"10.1021\/jm300871x","volume":"55","author":"J Cheung","year":"2012","unstructured":"Cheung J, Rudolph MJ, Burshteyn F et al (2012) Structures of human acetylcholinesterase in complex with pharmacologically important ligands. J Med Chem 55:10282\u201310286. https:\/\/doi.org\/10.1021\/jm300871x","journal-title":"J Med Chem"},{"key":"3148_CR37","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1039\/C9MD00358D","volume":"10","author":"JPB Lopes","year":"2019","unstructured":"Lopes JPB, Silva L, Ceschi MA et al (2019) Synthesis of new lophine\u2013carbohydrate hybrids as cholinesterase inhibitors: cytotoxicity evaluation and molecular modeling. Medchemcomm 10:2089\u20132101. https:\/\/doi.org\/10.1039\/C9MD00358D","journal-title":"Medchemcomm"},{"key":"3148_CR38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ejmech.2019.02.021","volume":"168","author":"K Chalupova","year":"2019","unstructured":"Chalupova K, Korabecny J, Bartolini M et al (2019) Novel tacrine-tryptophan hybrids: multi-target directed ligands as potential treatment for Alzheimer\u2019s disease. Eur J Med Chem 168:491\u2013514. https:\/\/doi.org\/10.1016\/j.ejmech.2019.02.021","journal-title":"Eur J Med Chem"},{"key":"3148_CR39","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T et al (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"key":"3148_CR40","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","volume":"24","author":"JR Greenwood","year":"2010","unstructured":"Greenwood JR, Calkins D, Sullivan AP, Shelley JC (2010) Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution. J Comput Aided Mol Des 24:591\u2013604. https:\/\/doi.org\/10.1007\/s10822-010-9349-1","journal-title":"J Comput Aided Mol Des"},{"key":"3148_CR41","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. method and assessment of docking accuracy. J Med Chem 47:1739\u20131749. https:\/\/doi.org\/10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"3148_CR42","doi-asserted-by":"publisher","first-page":"20356","DOI":"10.1039\/C9RA04105B","volume":"9","author":"SN Santos","year":"2019","unstructured":"Santos SN, Alves de Souza G, Pereira TM et al (2019) Regioselective microwave synthesis and derivatization of 1,5-diaryl-3-amino-1,2,4-triazoles and a study of their cholinesterase inhibition properties. RSC Adv 9:20356\u201320369. https:\/\/doi.org\/10.1039\/C9RA04105B","journal-title":"RSC Adv"},{"key":"3148_CR43","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/14756366.2019.1571270","volume":"34","author":"GA de Souza","year":"2019","unstructured":"de Souza GA, da Silva SJ, de Cistia CN et al (2019) Discovery of novel dual-active 3-(4-(dimethylamino)phenyl)-7-aminoalcoxy-coumarin as potent and selective acetylcholinesterase inhibitor and antioxidant. J Enzyme Inhib Med Chem 34:631\u2013637. https:\/\/doi.org\/10.1080\/14756366.2019.1571270","journal-title":"J Enzyme Inhib Med Chem"},{"key":"3148_CR44","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.foodchem.2011.10.110","volume":"132","author":"VS Gontijo","year":"2012","unstructured":"Gontijo VS, De Souza TC, Rosa IA et al (2012) Isolation and evaluation of the antioxidant activity of phenolic constituents of the Garcinia brasiliensis epicarp. Food Chem 132:1230\u20131235. https:\/\/doi.org\/10.1016\/j.foodchem.2011.10.110","journal-title":"Food Chem"},{"key":"3148_CR45","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.3390\/molecules23081902","volume":"23","author":"A Rampa","year":"2018","unstructured":"Rampa A, Bartolini M, Pruccoli L et al (2018) Exploiting the chalcone scaffold to develop multifunctional agents for Alzheimer\u2019s disease. Molecules 23:1902. https:\/\/doi.org\/10.3390\/molecules23081902","journal-title":"Molecules"},{"key":"3148_CR46","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neulet.2007.07.017","volume":"424","author":"A Tarozzi","year":"2007","unstructured":"Tarozzi A, Morroni F, Hrelia S et al (2007) Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells. Neurosci Lett 424:36\u201340. https:\/\/doi.org\/10.1016\/j.neulet.2007.07.017","journal-title":"Neurosci Lett"},{"key":"3148_CR47","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/cyto.a.10003","volume":"51A","author":"J Sebasti\u00e0","year":"2003","unstructured":"Sebasti\u00e0 J, Crist\u00f2fol R, Mart\u00edn M et al (2003) Evaluation of fluorescent dyes for measuring intracellular glutathione content in primary cultures of human neurons and neuroblastoma SH-SY5Y. Cytom Part A 51A:16\u201325. https:\/\/doi.org\/10.1002\/cyto.a.10003","journal-title":"Cytom Part A"},{"key":"3148_CR48","doi-asserted-by":"publisher","first-page":"e00023","DOI":"10.1002\/prp2.2349","volume":"2","author":"A Tarozzi","year":"2014","unstructured":"Tarozzi A, Bartolini M, Piazzi L et al (2014) From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer\u2019s disease. Pharmacol Res Perspect 2:e00023. https:\/\/doi.org\/10.1002\/prp2.2349","journal-title":"Pharmacol Res Perspect"},{"key":"3148_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/J.EJMECH.2018.01.066","volume":"147","author":"FP Dias Viegas","year":"2018","unstructured":"Dias Viegas FP, de Freitas Silva M, Divino da Rocha M et al (2018) Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: discovery of novel multi-target anti-alzheimer prototype drug candidates. Eur J Med Chem 147:48\u201365. https:\/\/doi.org\/10.1016\/J.EJMECH.2018.01.066","journal-title":"Eur J Med Chem"},{"key":"3148_CR50","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1021\/acs.jafc.7b04641","volume":"66","author":"F Morroni","year":"2018","unstructured":"Morroni F, Sita G, Djemil A et al (2018) Comparison of Adaptive Neuroprotective Mechanisms of Sulforaphane and its Interconversion Product Erucin in in Vitro and in Vivo Models of Parkinson\u2019s Disease. J Agric Food Chem 66:856\u2013865. https:\/\/doi.org\/10.1021\/acs.jafc.7b04641","journal-title":"J Agric Food Chem"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03148-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-020-03148-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-020-03148-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T08:23:03Z","timestamp":1634718183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-020-03148-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,20]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3148"],"URL":"https:\/\/doi.org\/10.1007\/s11064-020-03148-2","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,20]]},"assertion":[{"value":"23 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}